Voyager Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, VYGR, Voyager Therapeutics Inc, priceseries

Voyager Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
3.65
Close
3.93
High
4.03
Low
3.65
Previous Close
3.70
Daily Price Gain
0.23
YTD High
4.05
YTD High Date
Mar 1, 2022
YTD Low
2.60
YTD Low Date
Jan 24, 2022
YTD Price Change
0.94
YTD Gain
31.44%
52 Week High
6.08
52 Week High Date
Mar 10, 2021
52 Week Low
2.46
52 Week Low Date
Oct 5, 2021
52 Week Price Change
-1.57
52 Week Gain
-28.55%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 24. 2017
11.56
Apr 7. 2017
12.43
10 Trading Days
7.55%
Link
LONG
Aug 25. 2017
8.99
Oct 13. 2017
21.62
34 Trading Days
140.52%
Link
LONG
Jan 17. 2018
18.15
Jan 31. 2018
20.22
10 Trading Days
11.42%
Link
LONG
Feb 15. 2018
19.17
Mar 7. 2018
28.85
13 Trading Days
50.50%
Link
LONG
Feb 22. 2019
13.12
Mar 21. 2019
17.49
19 Trading Days
33.31%
Link
LONG
Mar 28. 2019
18.99
Apr 12. 2019
20.73
11 Trading Days
9.14%
Link
LONG
Feb 4. 2020
12.08
Feb 14. 2020
13.03
8 Trading Days
7.87%
Link
LONG
Apr 17. 2020
10.20
Apr 30. 2020
10.97
9 Trading Days
7.58%
Link
LONG
Jan 6. 2021
7.72
Jan 26. 2021
8.61
13 Trading Days
11.49%
Link
LONG
Jan 11. 2022
2.92
Jan 12. 2022
3.08
1 Trading Days
5.48%
Link
LONG
Feb 3. 2022
3.00
Feb 18. 2022
3.34
11 Trading Days
11.48%
Link
LONG
Feb 22. 2022
3.50
Mar 4. 2022
3.76
8 Trading Days
7.41%
Link
Company Information
Stock Symbol
VYGR
Exchange
NasdaqGS
Company URL
http://www.voyagertherapeutics.com
Company Phone
857-259-5340
CEO
Steven Marc Paul
Headquarters
Massachusetts
Business Address
75 SIDNEY STREET, CAMBRIDGE, MA 02139
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001640266
About

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops gene therapies for fatal and debilitating diseases of the central nervous system. It focuses in the field of adeno-associated virus gene therapy through innovation and investment in vector optimization and engineering, and dosing techniques, as well as process development and production. The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Description

Gene therapy biotech targeting Parkinson's disease and other CNS disorders.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading